Source comparison
Tesamorelin + Ipamorelin vs Single-Agent Protocols: Growth Hormone Response Comparison
Protocol differences determine whether you achieve tissue-level anabolism or just transient hormonal changes. Tesamorelin 1mg solo 12–18 1.5–2 22–28 1.4–1.9 Sharp pulse, rapid clearance. Limited anabolic window Ipamorelin 300mcg solo 6–9 3–4 15–20 0.9–1.3 Sust
This comparison does not assign a generated winner or score.
- Protocol differences determine whether you achieve tissue-level anabolism or just transient hormonal changes.
- Tesamorelin 1mg solo
- 12–18
- 1.5–2
- 22–28
- 1.4–1.9
- Sharp pulse, rapid clearance. Limited anabolic window
- Ipamorelin 300mcg solo
- 6–9
- 3–4
- 15–20
- 0.9–1.3
- Sustained but low amplitude. Insufficient for hypertrophy
- Tesamorelin 1mg + Ipamorelin 200mcg
- 16–24
- 4–6
- 38–45
- 2.8–3.8
- Synergistic amplitude and duration. Optimal for muscle accretion
- CJC-1295 + Ipamorelin
- 10–14
- 5–7
- 30–38
- 2.2–2.9
- Longer half-life but lower peak GH. Better for fat loss than hypertrophy
- The bottom line: dual-receptor stimulation produces both the peak GH required to activate IGF-1 transcription and the sustained elevation needed to maintain anabolic signalling across the 6–8 hour overnight window.